PTH and stem cells

Journal of Endocrinological Investigation

Volumn 34, Issue 7, 2011, Pages 552-556

  Ohishi, M ^a,b   Schipani, E ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Bone marrow; PTH; Stem cells; Stroma

Indexed keywords

PARATHYROID HORMONE;

BLOOD FLOW; BONE MARROW; CELL POPULATION; CELL TYPE; FIBROSIS; FIBROUS DYSPLASIA; FOOD AND DRUG ADMINISTRATION; HEMATOPOIETIC STEM CELL; HUMAN; HYPERPARATHYROIDISM; MESENCHYMAL STEM CELL; MICROENVIRONMENT; NONHUMAN; OSTEOCLAST; OSTEOPOROSIS; REVIEW; STEM CELL; STROMA CELL;

ANIMALS; BONE AND BONES; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLULAR MICROENVIRONMENT; HEMATOPOIETIC STEM CELLS; HUMANS; HYPERPARATHYROIDISM; MESENCHYMAL STEM CELLS; PARATHYROID HORMONE; PRIMARY MYELOFIBROSIS;

EID: 80054113294     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/7620     Document Type: Review

References (53)

1. Wu AM, Till JE, Siminovitch L, McCulloch EA. Cytological evidence for a relationship between normal hemotopoietic colony-forming cells and cells or the lymphoid system. J Exp Med 1968, 127: 455-64.
2. Morrison SJ, Weissman IL The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity 1994, 1: 661-73. (Pubitemid 124000730)
3. Ikuta K, Weissman IL Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. Proc Natl Acad Sci U S A 1992, 89: 1502-6.
4. Kiel MJ, Yilmaz OH, Iwashita T, Terhorst C, Morrison SJ. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 2005, 121: 1109-21. (Pubitemid 40884400)
5. Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 1970, 3: 393-403.
6. Friedenstein AJ, Chailakhyan RK, Latsinik NV, Panasyuk AF, Keiliss-Borok IV. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 1974, 17: 331-40.
7. Caplan AI. Mesenchymal stem cells. J Orthop Res 1991, 9: 641-50.
8. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284: 143-7. (Pubitemid 29282067)
9. Sacchetti B, Funari A, Michienzi S, et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 2007, 131: 324-36. (Pubitemid 47592917)
10. Méndez-Ferrer S, Michurina TV, Ferraro F, et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010, 466: 829-34.
11. Short B, Brouard N, Occhiodoro-Scott T, Ramakrishnan A, Simmons PJ. Mesenchymal stem cells. Arch Med Res 2003, 34: 565-71. (Pubitemid 38084710)
12. Tang Y, Wu X, Lei W, et al. TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med 2009, 15: 757-65.
13. Ohishi M, Schipani E. Bone marrow mesenchymal stem cells. J Cell Biochem 2010, 109: 277-82.
14. Olmsted-Davis EA, Gugala Z, Camargo F, et al. Primitive adult hematopoietic stem cells can function as osteoblast precursors. Proc Natl Acad Sci U S A 2003, 100: 15877-82. (Pubitemid 38021083)
15. Ogawa M, LaRue AC, Drake CJ. Hematopoietic origin of fibroblasts/ myofibroblasts: Its pathophysiologic implications. Blood 2006, 108: 2893-6.
16. Bellini A, Mattoli S. The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. Lab Invest 2007, 87: 858-70. (Pubitemid 47267815)
17. Kuwana M, Okazaki Y, Kodama H, Izumi K, Yasuoka H, Ogawa Y, Kawakami Y, Ikeda Y. Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation. J Leukoc Biol 2003, 74: 833-45. (Pubitemid 38040360)
18. Gensure RC, Gardella TJ, Jüppner H. Parathyroid hormone and parathyroid hormone-related peptide, and their receptors. Biochem Biophys Res Commun 2005, 328: 666-78. (Pubitemid 40208304)
19. Kearns AE, Khosla S, Kostenuik PJ. Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocr Rev 2008, 29: 155-92. (Pubitemid 351519689)
20. Lotinun S, Sibonga JD, Turner RT. Evidence that the cells responsible for marrow fibrosis in a rat model for hyperparathyroidism are preosteoblasts. Endocrinology 2005, 146: 4074-81. (Pubitemid 41175779)
21. Schofield R. The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells 1978, 4: 7-25. (Pubitemid 8376317)
22. Calvi LM, Adams GB, Weibrecht KW, et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003, 425: 841-6. (Pubitemid 37351468)
23. Zhang J, Niu C, Ye L, Huang H, et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425, 2003: 836-41. (Pubitemid 37351467)
24. Arai F, Hirao A, Ohmura M, et al. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 2004, 118: 149-61. (Pubitemid 38962572)
25. Katayama Y, Battista M, Kao WM, et al. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 2006, 124: 407-21. (Pubitemid 43121987)
26. Visnjic D, Kalajzic Z, Rowe DW, Katavic V, Lorenzo J, Aguila HL. Hematopoiesis is severely altered in mice with an induced osteoblast deficiency. Blood 2004, 103: 3258-64. (Pubitemid 38525648)
27. Adams GB, Scadden DT. The hematopoietic stem cell in its place. Nat Immunol 2006, 7: 333-7.
28. Yin T, Li L The stem cell niches in bone. J Clin Invest 2006, 116: 1195-201.
29. Calvi LM. Osteoblastic activation in the hematopoietic stem cell niche. Ann N Y Acad Sci 2006, 1068: 477-88. (Pubitemid 43824176)
30. Adams GB, Martin RP, Alley IR, et al. Therapeutic targeting of a stem cell niche. Nat Biotechnol 2007, 25: 238-43. (Pubitemid 46227124)
31. Ballen KK, Shpall EJ, Avigan D, et al. Phase I trial of parathyroid hormone to facilitate stem cell mobilization. Biol Blood Marrow Transplant 2007, 13: 838-43. (Pubitemid 46902439)
32. Omatsu Y, Sugiyama T, Kohara H, et al. The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche. Immunity 2010, 33: 387-99.
33. Black DM, Greenspan SL, Ensrud KE, et al. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med 2003, 349: 1207-15. (Pubitemid 37152030)
34. Finkelstein JS, Hayes A, Hunzelman JL, Wyland JJ, Lee H, Neer RM. The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N Engl J Med 2003, 349: 1216-26. (Pubitemid 37152031)
35. Wu X, Pang L, Lei W, et al. Inhibition of Sca-1-positive skeletal stem cell recruitment by alendronate blunts the anabolic effects of parathyroid hormone on bone remodeling. Cell Stem Cell 2010, 7: 571-80.
36. Kuter DJ, Bain B, Mufti G, Bagg A, Hasserjian RP. Bone marrow fibrosis: pathophysiology and clinical significance of increased bone marrow stromal fibres. Br J Haematol 2007, 139: 351-62. (Pubitemid 47512180)
37. Rao DS, Shih MS, Mohini R. Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia. N Engl J Med 1993, 328: 171-5. (Pubitemid 23021503)
38. Kumbasar B, Taylan I, Kazancioglu R, Agan M, Yenigun M, Sar F. Myelofibrosis secondary to hyperparathyroidism. Exp Clin Endocrinol Diabetes 2004, 112: 127-30. (Pubitemid 38445491)
39. Lim DJ, Oh EJ, Park CW, et al. Pancytopenia and secondary myelofibrosis could be induced by primary hyperparathyroidism. Int J Lab Hematol 2007, 29: 464-8. (Pubitemid 350060616)
40. Riminucci M, Robey PG, Saggio I, Bianco P. Skeletal progenitors and the GNAS gene: fibrous dysplasia of bone read through stem cells. J Mol Endocrinol 2010, 45: 355-64.
41. Turner RT, Iwaniec UT, Marley K, Sibonga JD. The role of mast cells in parathyroid bone disease. J Bone Miner Res 2010, 25: 1637-49.
42. Calvi LM, Sims NA, Hunzelman JL, et al. Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells, differentially affects cortical and trabecular bone. J Clin Invest 2001, 107: 277-86. (Pubitemid 32157960)
43. Halasy-Nagy JM, Rodan GA, Reszka AA. Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis. Bone 2001, 29: 553-9. (Pubitemid 33124298)
44. Ohishi M, Chiusaroli R, Ominsky M, et al. Osteoprotegerin abrogated cortical porosity and bone marrow fibrosis in a mouse model of constitutive activation of the PTH/PTHrP receptor. Am J Pathol 2009, 174: 2160-71.
45. Yamamoto T, Ozono K, Kasayama S, et al. Increased IL-6-produc-tion by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome. J Clin Invest 1996, 98: 30-5. (Pubitemid 26243817)
46. Piersanti S, Remoli C, Saggio I, et al. Transfer, analysis, and reversion of the fibrous dysplasia cellular phenotype in human skeletal progenitors. J Bone Miner Res 2010, 25: 1103-16.
47. Glorieux FH, Rauch F. Medical therapy of children with fibrous dysplasia. J Bone Miner Res 2006, 21 (Suppl 2): P110-3.
48. Chapurlat RD. Medical therapy in adults with fibrous dysplasia of bone. J Bone Miner Res 2006, 21 (Suppl 2): P114-9.
49. Calvi LM, Schipani E. The PTH/PTHrP receptor in Jansen's metaphyseal chondrodysplasia. J Endocrinol Invest 2000, 23: 545-54.
50. Guo J, Liu M, Yang D, et al. Phospholipase C signaling via the parathyroid hormone (PTH)/PTH-related peptide receptor is essential for normal bone responses to PTH. Endocrinology 2010, 151: 3502-13.
51. Guo J, Liu M, Yang D, et al. Suppression of Wnt signaling by Dkk1 attenuates PTH-mediated stromal cell response and new bone formation. Cell Metab 2010, 11: 161-71.
52. Kousteni S, Bilezikian JP. The cell biology of parathyroid hormone in osteoblasts. Curr Osteoporos Rep 2008, 6: 72-6.
53. Datta NS, Abou-Samra AB. PTH and PTHrP signaling in osteoblasts. Cell Signal 2009, 21: 1245-54.